Replies to post #7439 on Oncolix Inc. (fka ONCX)

[reaper247]

Yes, that is true.

But who is to say what “cheap” shares are?

If Oncolix goes public and has an eventual NASDAQ listing, .20 is cheap (from what we know at this time, it is a real possibility.)

If Prolanta clears FDA hurdles, $2.00 is cheap.

If a publically traded Oncolix, listed on the NASDAQ has a share price high enough to support options trading ($10-$20,) that is FU$ for current AEPP shareholders.

An AEPP shareholder could contact their broker and request a level 1 trading tier status and become a covered call options trader.

Once approved, that shareholder could potentially collect $1 in premium for every monthly contract they write, near or out of the money depending on demand.

By selling 10 contracts in a month, with each contract representing 100 shares, they could potentially collect $1000 a month on the contracts alone.

Here is the beauty of that.

If the price does not reach the agreed upon strike price, that Oncolix shareholder keeps both the premium and their shares, to collect premium again the following month by writing new contracts.

If that strike price is reached, that same holder will keep the premium and their shares are “called away” at the higher price.

That means the shareholder is both keeping the premium AND selling their shares at the higher price to whoever purchased the contracts.

Any gains or losses from there are the responsibility of those who executed those contracts.

Just saying that even current AEPP shareholders with modest positions could potentially see gains that haven’t even been discussed much here.

Long story short, a ten bagger is a nice gainer and everyone should take profits and risk off the table on the upticks.

But if I honestly thought .20 was a top, I wouldn’t still be here posting.

IMO and FWIW.